Publicaciones en colaboración con investigadoras/es de Hospital Clínico San Carlos de Madrid (17)

2022

  1. Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis

    Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163

2020

  1. A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  2. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

2013

  1. Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

    Journal of Medical Genetics, Vol. 50, Núm. 1, pp. 25-33

  2. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782

  3. TNFRSF1A polymorphisms rs1800693 and rs4l49584 in patients with multiple sclerosis

    Neurology, Vol. 80, Núm. 22, pp. 2010-2016

2012

  1. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci

    Genes and Immunity, Vol. 13, Núm. 3, pp. 253-257

  2. Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

    Journal of Neuroimmunology, Vol. 245, Núm. 1-2, pp. 98-101

  3. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990

  4. Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects

    Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562

  5. Replication study of 10 genes showing evidence for association with multiple sclerosis: Validation of TMEM39A, IL12B and CLBL genes

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 959-965

2011

  1. IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

    Journal of Neuroimmunology, Vol. 239, Núm. 1-2, pp. 101-104

  2. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain

    Genes and Immunity, Vol. 12, Núm. 2, pp. 110-115

  3. Validation of IRF5 as multiple sclerosis risk gene: Putative role in interferon beta therapy and human herpes virus-6 infection

    Genes and Immunity, Vol. 12, Núm. 1, pp. 40-45

2010

  1. IFN-β pharmacogenomics in multiple sclerosis

    Pharmacogenomics, Vol. 11, Núm. 8, pp. 1137-1148

  2. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

    Genes and Immunity, Vol. 11, Núm. 5, pp. 439-445

  3. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain

    Journal of Neuroimmunology, Vol. 223, Núm. 1-2, pp. 100-103